top of page
Biologics CMC Series, Part 6: Biologics Process Validation — Are Three Batches Enough for Commercial Manufacturing?
Are three batches enough? Explore the process validation lifecycle, PPQ evidence, and continued monitoring through a hypothetical monoclonal antibody program.

Jason Lu
Sep 207 min read


Biologics CMC Series (4): Biologics Control Strategy—Integrating Process, Analytics, and Regulatory Requirements
Biologics quality cannot rely on release testing alone. This guide explains how to build an integrated strategy across materials, manufacturing, analytics, specifications, and continued monitoring.

Jason Lu
Aug 3011 min read
bottom of page
